157 related articles for article (PubMed ID: 2018922)
1. Anxiety levels in dreams: relation to localized cerebral glucose metabolic rate.
Gottschalk LA; Buchsbaum MS; Gillin JC; Wu JC; Reynolds CA; Herrera DB
Brain Res; 1991 Jan; 538(1):107-10. PubMed ID: 2018922
[TBL] [Abstract][Full Text] [Related]
2. The relationship between social alienation and disorganized thinking in normal subjects and localized cerebral glucose metabolic rates assessed by positron emission tomography.
Gottschalk LA; Fronczek J; Abel L; Buchsbaum MS
Compr Psychiatry; 1992; 33(5):332-41. PubMed ID: 1395553
[TBL] [Abstract][Full Text] [Related]
3. Positron-emission tomographic studies of the relationship of cerebral glucose metabolism and the magnitude of anxiety and hostility experienced during dreaming and waking.
Gottschalk LA; Buchsbaum MS; Gillin JC; Wu J; Reynolds CA; Herrera DB
J Neuropsychiatry Clin Neurosci; 1991; 3(2):131-42. PubMed ID: 1821226
[TBL] [Abstract][Full Text] [Related]
4. The effect of anxiety and hostility in silent mentation on localized cerebral glucose metabolism.
Gottschalk LA; Buchsbaum MS; Gillin JC; Wu J; Reynolds CA; Herrera DB
Compr Psychiatry; 1992; 33(1):52-9. PubMed ID: 1555410
[TBL] [Abstract][Full Text] [Related]
5. The cerebral neurobiology of anxiety, anxiety displacement, and anxiety denial.
Gottschalk LA; Fronczek J; Abel L; Buchsbaum MS; Fallon JH
Psychother Psychosom; 2001; 70(1):17-24. PubMed ID: 11150934
[TBL] [Abstract][Full Text] [Related]
6. Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming.
Heiss WD; Pawlik G; Herholz K; Wagner R; Wienhard K
Brain Res; 1985 Feb; 327(1-2):362-6. PubMed ID: 3872693
[TBL] [Abstract][Full Text] [Related]
7. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
[TBL] [Abstract][Full Text] [Related]
8. Cerebral glucose metabolic differences in patients with panic disorder.
Nordahl TE; Semple WE; Gross M; Mellman TA; Stein MB; Goyer P; King AC; Uhde TW; Cohen RM
Neuropsychopharmacology; 1990 Aug; 3(4):261-72. PubMed ID: 2400544
[TBL] [Abstract][Full Text] [Related]
9. Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography.
Buchsbaum MS; Gillin JC; Wu J; Hazlett E; Sicotte N; Dupont RM; Bunney WE
Life Sci; 1989; 45(15):1349-56. PubMed ID: 2796606
[TBL] [Abstract][Full Text] [Related]
10. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
Schmidt KC; Lucignani G; Sokoloff L
J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
[No Abstract] [Full Text] [Related]
12. [Tomographic measurement of human cerebral glucose metabolism].
Iwasaki Y; Konishi J; Makada Y; Yonekura Y
Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
[No Abstract] [Full Text] [Related]
13. Patterns of cerebral glucose metabolism using 18FDG and positron tomography in the neurologic investigation of the full term newborn infant.
Thorp PS; Levin SD; Garnett ES; Nahmias C; Firnau G; Toi A; Upton AR; Nobbs PT; Sinclair JC
Neuropediatrics; 1988 Aug; 19(3):146-53. PubMed ID: 3265490
[TBL] [Abstract][Full Text] [Related]
14. Regional cerebral glucose metabolism compared in rodents and humans.
Blin J; Ray CA; Chase TN; Piercey MF
Brain Res; 1991 Dec; 568(1-2):215-22. PubMed ID: 1814569
[TBL] [Abstract][Full Text] [Related]
15. Localized and lateralized cerebral glucose metabolism associated with eye movements during REM sleep and wakefulness: a positron emission tomography (PET) study.
Hong CC; Gillin JC; Dow BM; Wu J; Buchsbaum MS
Sleep; 1995 Sep; 18(7):570-80. PubMed ID: 8552928
[TBL] [Abstract][Full Text] [Related]
16. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
17. The effect of naloxone on cerebral blood flow and glucose metabolism in patients with complex partial seizures.
Theodore WH; Leiderman D; Gaillard W; Khan I; Reeves P; Lloyd-Hontz K
Epilepsy Res; 1993 Sep; 16(1):51-4. PubMed ID: 8243439
[TBL] [Abstract][Full Text] [Related]
18. Age differences in intercorrelations between regional cerebral metabolic rates for glucose.
Horwitz B; Duara R; Rapoport SI
Ann Neurol; 1986 Jan; 19(1):60-7. PubMed ID: 3484930
[TBL] [Abstract][Full Text] [Related]
19. What are the sources of error in measuring and calculating cerebral metabolic rates with fluorine-18-fluorodeoxyglucose and PET?
Alavi A; Smith R; Duncan D
J Nucl Med; 1994 Sep; 35(9):1466-70. PubMed ID: 8071693
[No Abstract] [Full Text] [Related]
20. Simplified calculation of MRglc using PET.
Phillips RL; London ED
J Nucl Med; 1997 Aug; 38(8):1334. PubMed ID: 9255178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
